| On racism: a new standard for publishing on racial health inequities RW Boyd, EG Lindo, LD Weeks, MR McLemore Health Affairs Forefront, 2020 | 714 | 2020 |
| Monoclonal gammopathy of undetermined significance TH Mouhieddine, LD Weeks, IM Ghobrial Blood, The Journal of the American Society of Hematology 133 (23), 2484-2494, 2019 | 92 | 2019 |
| Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair AD Bulgar, LD Weeks, Y Miao, S Yang, Y Xu, C Guo, S Markowitz, ... Cell death & disease 3 (1), e252-e252, 2012 | 85 | 2012 |
| Uracil–DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed LD Weeks, P Fu, SL Gerson Molecular cancer therapeutics 12 (10), 2248-2260, 2013 | 82 | 2013 |
| Prediction of risk for myeloid malignancy in clonal hematopoiesis LD Weeks, A Niroula, D Neuberg, W Wong, RC Lindsley, MR Luskin, ... NEJM evidence 2 (5), EVIDoa2200310, 2023 | 80 | 2023 |
| TET2-mutant clonal hematopoiesis and risk of gout M Agrawal, A Niroula, P Cunin, M McConkey, V Shkolnik, PG Kim, ... Blood, The Journal of the American Society of Hematology 140 (10), 1094-1103, 2022 | 69 | 2022 |
| Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed LD Weeks, GE Zentner, PC Scacheri, SL Gerson Cell death & disease 5 (2), e1045-e1045, 2014 | 46 | 2014 |
| Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease ED Gumuser, A Schuermans, SMJ Cho, ZA Sporn, MM Uddin, ... Journal of the American College of Cardiology 81 (20), 1996-2009, 2023 | 29 | 2023 |
| Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia LD Weeks, CR Marinac, R Redd, G Abel, A Lin, M Agrawal, RM Stone, ... Blood, The Journal of the American Society of Hematology 139 (8), 1246-1250, 2022 | 19 | 2022 |
| Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine NL Oleinick, T Biswas, R Patel, M Tao, R Patel, L Weeks, N Sharma, ... Radiotherapy and Oncology 121 (2), 335-341, 2016 | 17 | 2016 |
| Low-energy electron-induced oligomerization of condensed carbon tetrachloride LD Weeks, LL Zhu, M Pellon, DR Haines, CR Arumainayagam The Journal of Physical Chemistry C 111 (12), 4815-4822, 2007 | 15 | 2007 |
| Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia S Shimony, Y Liu, YK Valtis, JD Paolino, AE Place, AM Brunner, ... Blood Advances 7 (7), 1092-1102, 2023 | 13 | 2023 |
| Causes and consequences of clonal hematopoiesis LD Weeks, BL Ebert Blood 142 (26), 2235-2246, 2023 | 8 | 2023 |
| Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support AI Lee, LE Masselink, LM De Castro, AL Marshall, NT Connell, GA Dent, ... Blood advances 7 (13), 3058-3068, 2023 | 7 | 2023 |
| Impact of COVID-19 on hematology-oncology fellowship programs: A quantitative and qualitative survey assessment of fellowship program directors AI Velazquez, U Durani, LD Weeks, A Major, R Reynolds, A Kumbamu, ... JCO Oncology Practice 18 (4), e551-e563, 2022 | 7 | 2022 |
| Impact of COVID-19 on hematology-oncology trainees: A quantitative and qualitative assessment U Durani, A Major, AI Velazquez, J May, M Nelson, Z Zheng, AG Hall, ... JCO oncology practice 18 (4), e586-e599, 2022 | 7 | 2022 |
| When the patient is racist, how should the doctor respond LD Weeks STAT, 2017 | 7 | 2017 |
| Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias A Schuermans, C Vlasschaert, V Nauffal, SMJ Cho, MM Uddin, T Nakao, ... European Heart Journal 45 (10), 791-805, 2024 | 6 | 2024 |
| Prediction of risk for myeloid malignancy in clonal hematopoiesis LD Weeks, A Niroula, DS Neuberg, WJ Wong, RC Lindsley, MR Luskin, ... Blood 140 (Supplement 1), 2229-2231, 2022 | 6 | 2022 |
| Molecular characterization of adult acute lymphoblastic leukemia identifies a subgroup with myeloid mutations and pre-existing clonal hematopoiesis C Saygin, J Stauber, I Aldoss, AS Sperling, LD Weeks, MR Luskin, ... Blood 140 (Supplement 1), 1050-1052, 2022 | 5 | 2022 |
